JP2005516073A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516073A5
JP2005516073A5 JP2003564071A JP2003564071A JP2005516073A5 JP 2005516073 A5 JP2005516073 A5 JP 2005516073A5 JP 2003564071 A JP2003564071 A JP 2003564071A JP 2003564071 A JP2003564071 A JP 2003564071A JP 2005516073 A5 JP2005516073 A5 JP 2005516073A5
Authority
JP
Japan
Prior art keywords
diabetes
subject
type
pipkiiβ
suspected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003564071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/003065 external-priority patent/WO2003064451A2/en
Publication of JP2005516073A publication Critical patent/JP2005516073A/ja
Publication of JP2005516073A5 publication Critical patent/JP2005516073A5/ja
Pending legal-status Critical Current

Links

JP2003564071A 2002-02-01 2003-02-03 ＩＩβ型ホスホイノシチドリン酸キナーゼの調節 Pending JP2005516073A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35375802P 2002-02-01 2002-02-01
PCT/US2003/003065 WO2003064451A2 (en) 2002-02-01 2003-02-03 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE

Publications (2)

Publication Number Publication Date
JP2005516073A JP2005516073A (ja) 2005-06-02
JP2005516073A5 true JP2005516073A5 (enExample) 2006-03-23

Family

ID=27663251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003564071A Pending JP2005516073A (ja) 2002-02-01 2003-02-03 ＩＩβ型ホスホイノシチドリン酸キナーゼの調節

Country Status (5)

Country Link
US (1) US20060089320A1 (enExample)
EP (1) EP1481093A4 (enExample)
JP (1) JP2005516073A (enExample)
CA (1) CA2473990A1 (enExample)
WO (1) WO2003064451A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012112245A1 (en) * 2011-02-14 2012-08-23 Beth Israel Deaconess Medical Center, Inc. Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
WO2014068070A1 (en) 2012-10-31 2014-05-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for preventing antiphospholipid syndrome (aps)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291172B1 (en) * 1995-03-03 2001-09-18 Mitokor Diagnostic assay for diabetes mellitus based on mutational burden
AU712607B2 (en) * 1996-02-02 1999-11-11 Merck & Co., Inc. Method of treating diabetes and related disease states
AU4724099A (en) * 1998-06-26 2000-01-17 University Of Utah Research Foundation Immobilized reagents for kinase assays
CN1321756A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人磷脂酰肌－4－磷酸－5－激酶Ⅱbeta亚基13和编码这种多肽的多核苷酸
WO2001094629A2 (en) * 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets

Similar Documents

Publication Publication Date Title
JP2005518433A5 (enExample)
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
JP2007510667A5 (enExample)
JP2007523178A5 (enExample)
JP2006502236A5 (enExample)
HUS1500021I1 (hu) 1,2,4-oxadiazol-benzoesav vegyületek és alkalmazásuk nonszensz szupresszióra és a betegség kezelésére
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
JP2006514116A5 (enExample)
EA200870091A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли
EA200870088A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови
IL177437A (en) Use of a ctgf inhibitor in the preparation of a proteinuria treatment for diabetes mellitus
JP2005516073A5 (enExample)
RU2002135207A (ru) Средство "арголит" для лечения инфицированных ран
RU2008124830A (ru) Производное рапамицина или ингибитор impdh для лечения поликистозного заболевания почек
RU2004123072A (ru) Способ лечения больных остеоартрозом
HK1123995A (en) Compounds and methods for treatment of stroke
RU2005118619A (ru) Способ лечения артериальной гипертонии
JP2002533400A5 (enExample)
WO2007117272A3 (en) Methods for treatment of hemorrhagic shock and related disorders
RU2002120295A (ru) Способ прогнозирования эффективности лечения золофтом депрессивных состояний
RU2005129591A (ru) Способ лечения хронической сердечной недостаточности
RU2005140708A (ru) Способ лечения остеоартроза, осложненного реактивным синовитом
RU2006117464A (ru) Способ профилактики осложнений, возникающих при лечении позвоночника с использованием металлоконструкций
RU2001129744A (ru) Способ лечения бациллярных форм туберкулеза легких
RU2003109100A (ru) Способ лечения гемангиом у детей